1. Home
  2. BJDX vs MEHA Comparison

BJDX vs MEHA Comparison

Compare BJDX & MEHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluejay Diagnostics Inc.

BJDX

Bluejay Diagnostics Inc.

N/A

Current Price

$5.52

Market Cap

1.8M

Sector

Health Care

ML Signal

N/A

MEHA

Functional Brands Inc.

N/A

Current Price

$0.08

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BJDX
MEHA
Founded
2015
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
2.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BJDX
MEHA
Price
$5.52
$0.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.0M
68.6M
Earning Date
05-12-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
86.65
N/A
EPS
N/A
N/A
Revenue
$249,040.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.06
52 Week High
$7.00
$0.74

Technical Indicators

Market Signals
Indicator
BJDX
MEHA
Relative Strength Index (RSI) 93.74 44.01
Support Level $1.46 $0.06
Resistance Level N/A $0.22
Average True Range (ATR) 0.54 0.02
MACD 0.38 0.00
Stochastic Oscillator 73.22 21.29

Price Performance

Historical Comparison
BJDX
MEHA

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

About MEHA Functional Brands Inc.

Functional Brands Inc operates in the nutraceutical supplement industry. It is a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, brain and memory, sleep, prenatal and urinary. It is focus on end-consumers through different channels that include pharmacies, wholesalers, international distributors and direct-to-consumers sales. The Company has two reportable segments: 1) Kirkman, which sells a range of nutraceuticals, supplements and related products direct to consumers; 2) HT Naturals, which sells a range of hemp products. Key revenue is generated from Kirkman.

Share on Social Networks: